Palisade Bio vs VivoSim Labs
PALI and VIVS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PALI and VIVS compare
Palisade Bio is the larger company, worth 459 times as much as VivoSim Labs ($176M against $384K).
Palisade Bio keeps more of each dollar of sales as profit, with a net margin of −6388% compared with −11016% at VivoSim Labs.
Palisade Bio scores higher on the StockData Score (7 against 5 for VivoSim Labs), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PALI | VIVS |
|---|---|---|
| Size and price | ||
| Market cap | $176M | $384K |
| Share price | $1.01 | $0.120 |
| Change, 1 year | −52.8% | −94.5% |
| Change, 5 years | −99.9% | −99.8% |
| Beta (5Y) | 1.15 | 2.58 |
| Employees | 100K | 15 |
| StockData Score | ||
| Total score | 7 (better) | 5 |
| Valuation score | 1 | 1 |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 5 (better) | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 352× | 3.4× (better) |
| P/B | 1.4× | – |
| FCF yield | – | −2639% |
| Growth | ||
| Revenue growth (TTM) | – | −21.1% |
| Profitability | ||
| Operating margin | −7070% (better) | −10117% |
| Net margin | −6388% (better) | −11016% |
| FCF margin | – | −9038% |
| Return on equity | −51.4% (better) | −343% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | −4418.6× | −944.3× (better) |
| Current ratio | 24.26 (better) | 1.70 |
| Altman Z-score | 19.21 (better) | −139.28 |
| Piotroski F-score | 4 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | −74.7% (better) | −781% |
| Shareholder yield | −74.7% (better) | −781% |
| Ownership | ||
| Held by institutions | 99.5% | 3.2% |
| Held by insiders | 4.7% | – |
| Insider net buying, 12 months | −$124K | $2.8K (better) |
| Short interest, % of float | 17.6% | – |
Go deeper
- PALI stock overview
- PALI income statement
- PALI valuation and score
- VIVS stock overview
- VIVS income statement
- VIVS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.